The Glycotope-Specific RAV12 Monoclonal Antibody Induces Oncosis in Vitro and Has Antitumor Activity Against Gastrointestinal Adenocarcinoma Tumor Xenografts in Vivo

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0581
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phase 1 Experience With an Anti-Glycotope Monoclonal Antibody, RAV12, in Recurrent Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

90y-Labeled Anti-Robo1 Monoclonal Antibody Exhibits Antitumor Activity Against Small Cell Lung Cancer Xenografts

PLoS ONE
Multidisciplinary
2015English

Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model

Cancer Research
Cancer ResearchOncology
2012English

Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy in Vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified With Cancer-Specific Monoclonal Antibody

Clinical Cancer Research
Cancer ResearchOncology
2009English

A Neutralizing Anti-Fibroblast Growth Factor 8 Monoclonal Antibody Shows Potent Antitumor Activity Against Androgen-Dependent Mouse Mammary Tumors in Vivo

Clinical Cancer Research
Cancer ResearchOncology
2005English

Antitumor Activity of Rhein Lysinate Against Human Glioma U87 Cells in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

PF-03732010: A Fully Human Monoclonal Antibody Against P-Cadherin With Antitumor and Antimetastatic Activity

Clinical Cancer Research
Cancer ResearchOncology
2010English

Antitumor Activity of SPM VIII, a Derivative of the Nucleoside Antibiotic Spicamycin, Against Human Tumor Xenografts.

Journal of Antibiotics
Drug DiscoveryPharmacology
1994English

Fluopsin C Induces Oncosis of Human Breast Adenocarcinoma Cells

Acta Pharmacologica Sinica
MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy